These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 9822057)

  • 1. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range.
    Hirsh J; Dalen JE; Anderson DR; Poller L; Bussey H; Ansell J; Deykin D; Brandt JT
    Chest; 1998 Nov; 114(5 Suppl):445S-469S. PubMed ID: 9822057
    [No Abstract]   [Full Text] [Related]  

  • 2. Current recommendations for warfarin therapy. Use and monitoring.
    Triplett DA
    Med Clin North Am; 1998 May; 82(3):601-11. PubMed ID: 9646782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral anticoagulants. Mechanism of action, clinical effectiveness, and optimal therapeutic range.
    Hirsh J; Dalen JE; Deykin D; Poller L; Bussey H
    Chest; 1995 Oct; 108(4 Suppl):231S-246S. PubMed ID: 7555179
    [No Abstract]   [Full Text] [Related]  

  • 4. [Oral anticoagulants treatment of thrombosis].
    Matsuda T
    Nihon Naika Gakkai Zasshi; 1995 Sep; 84(9):1523-7. PubMed ID: 8537761
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral anticoagulants in clinical practice.
    Brozović M
    Semin Hematol; 1978 Jan; 15(1):27-34. PubMed ID: 622584
    [No Abstract]   [Full Text] [Related]  

  • 6. Oral anticoagulant initiation: rationale for the use of warfarin dosing nomograms.
    Crowther MA
    Semin Vasc Med; 2003 Aug; 3(3):255-60. PubMed ID: 15199458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidelines on oral anticoagulation with warfarin - fourth edition.
    Keeling D; Baglin T; Tait C; Watson H; Perry D; Baglin C; Kitchen S; Makris M;
    Br J Haematol; 2011 Aug; 154(3):311-24. PubMed ID: 21671894
    [No Abstract]   [Full Text] [Related]  

  • 8. Dietary implications for patients receiving long-term oral anticoagulation therapy for treatment and prevention of thromboembolic disease.
    Kampouraki E; Kamali F
    Expert Rev Clin Pharmacol; 2017 Aug; 10(8):789-797. PubMed ID: 28635328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral anticoagulants. Mechanism of action, clinical effectiveness, and optimal therapeutic range.
    Hirsh J; Dalen JE; Deykin D; Poller L
    Chest; 1992 Oct; 102(4 Suppl):312S-326S. PubMed ID: 1345417
    [No Abstract]   [Full Text] [Related]  

  • 10. The perioperative management of warfarin therapy.
    Ansell JE
    Arch Intern Med; 2003 Apr; 163(8):881-3. PubMed ID: 12719195
    [No Abstract]   [Full Text] [Related]  

  • 11. Incorporating Comprehensive Management of Direct Oral Anticoagulants into Anticoagulation Clinics.
    Mohammad I; Korkis B; Garwood CL
    Pharmacotherapy; 2017 Oct; 37(10):1284-1297. PubMed ID: 28730690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New protocols for perioperative management of podiatric patients taking oral anticoagulants.
    Lanzat M; Danna AT; Jacobson DS
    J Foot Ankle Surg; 1994; 33(1):16-20. PubMed ID: 8161987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An oral vitamin K protocol to reverse over-anticoagulation in patients presenting with an International Normalised Ratio above 10.0.
    Denas G; Cucchini U; Iliceto S; Pengo V
    Thromb Haemost; 2009 Feb; 101(2):410-1. PubMed ID: 19190831
    [No Abstract]   [Full Text] [Related]  

  • 14. Oral anticoagulants and regional anesthesia: a perspective.
    Enneking FK; Benzon H
    Reg Anesth Pain Med; 1998; 23(6 Suppl 2):140-5. PubMed ID: 9845386
    [No Abstract]   [Full Text] [Related]  

  • 15. Voriconazole potentiates warfarin-induced prothrombin time prolongation.
    Purkins L; Wood N; Kleinermans D; Nichols D
    Br J Clin Pharmacol; 2003 Dec; 56 Suppl 1(Suppl 1):24-9. PubMed ID: 14616410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence to long-term warfarin therapy remains challenging.
    Ward M
    J Manag Care Pharm; 2013 May; 19(4):290. PubMed ID: 23627574
    [No Abstract]   [Full Text] [Related]  

  • 17. Secondary prophylaxis of venous thromboembolism: rational use of oral anticoagulants.
    Piovella F; Siragusa S; Barone M; Beltrametti C; Carbone S; Vicentini L; Ascari E
    Haematologica; 1995; 80(2 Suppl):87-91. PubMed ID: 7543072
    [No Abstract]   [Full Text] [Related]  

  • 18. [Fifty years of clinical use of warfarin].
    Quintero-González JA
    Invest Clin; 2010 Jun; 51(2):269-87. PubMed ID: 20928982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Warfarin or acenocoumarol: which is better in the management of oral anticoagulants?
    Barcellona D; Vannini ML; Fenu L; Balestrieri C; Marongiu F
    Thromb Haemost; 1998 Dec; 80(6):899-902. PubMed ID: 9869157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated international normalized ratio from vitamin K supplement discontinuation.
    Miesner AR; Sullivan TS
    Ann Pharmacother; 2011 Jan; 45(1):e2. PubMed ID: 21205949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.